Greatbatch slips to loss in Q3 with Swiss plant closure costs

Mon, 10/29/2012 - 3:49pm
Mass Device

Greatbatch's increases 22% during its 3rd quarter, but the medical device maker posts net losses of $ 7.6 million in due to operational issues at its Swiss facilities.

Greatbatch logo

Medical device maker Greatbatch (NYSE:GB) lost $7.6 million in 3Q, the result of the nearly $15 million in expense to close a pair of Swiss factories.

The Clarence, N.Y.-based company lost 32¢ per share, on sales of $161.3 million during the 3 months ended Sept. 28, 2012. That compared with a profit of $7 million, or 30¢ per share, on sales of $131.7 million during the same period last year.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.